What is the appropriate management for acute sinus infection?

Management of Acute Sinus Infection

Start with amoxicillin (with or without clavulanate) for 5-10 days if you decide to treat acute bacterial rhinosinusitis with antibiotics, but watchful waiting without antibiotics is equally appropriate for uncomplicated cases. 1, 2

Distinguishing Bacterial from Viral Sinusitis

Before treating, you must differentiate acute bacterial rhinosinusitis (ABRS) from viral upper respiratory infections. Diagnose ABRS only when patients meet one of these three criteria: 3, 1

• Persistent symptoms lasting ≥10 days without improvement (nasal congestion, purulent discharge, facial pain, cough) 4, 5, 3
• Severe symptoms with high fever (≥39°C/102°F) and purulent nasal discharge or facial pain for at least 3-4 consecutive days at illness onset 5, 3
• "Double-sickening" pattern: initial improvement from viral URI followed by worsening symptoms (new fever, headache, increased nasal discharge) after 5-6 days 5, 3

Critical pitfall: Symptoms lasting fewer than 7 days are almost never bacterial—these patients do not need antibiotics. 6 Most acute rhinosinusitis cases (98-99.5%) are viral and resolve spontaneously. 7

Initial Management Decision

Watchful Waiting (Preferred for Most Patients)

Offer watchful waiting without antibiotics as first-line management for all patients with uncomplicated ABRS, regardless of symptom severity. 1, 2 This represents a major shift from older guidelines that restricted this approach to "mild" cases only.

Provide symptomatic treatment: 4

• Analgesics for pain (assess and treat based on severity) 4
• Adequate hydration and rest 4
• Saline nasal irrigation 5, 1
• Decongestants (systemic or topical) 4, 6
• Warm facial packs, steamy showers 4
• Sleep with head elevated 4

When to Prescribe Antibiotics Initially

Reserve immediate antibiotic therapy for: 5, 6

• Patients with severe symptoms (high fever, severe unilateral facial pain/swelling) 5, 6
• Patients at risk for antibiotic resistance (age <2 or >65, daycare exposure, recent antibiotics within past month, recent hospitalization, comorbidities, immunocompromised) 3

Antibiotic Selection

First-line therapy: Amoxicillin with or without clavulanate for 5-10 days 1, 2

This differs from older guidelines recommending amoxicillin alone. 4 The 2015 update changed to amoxicillin-clavulanate as preferred due to increasing resistance patterns, though both remain acceptable. 1, 2

Dosing for high-dose amoxicillin-clavulanate: 90 mg/kg amoxicillin and 6.4 mg/kg clavulanate, not exceeding 2g every 12 hours 4

Alternative agents for penicillin allergy or intolerance: 4

• Cephalosporins (cefuroxime, cefpodoxime, cefprozil, cefdinir)
• Doxycycline
• Respiratory fluoroquinolones
• Macrolides

For regions with high antibiotic resistance or treatment failure: Use high-dose amoxicillin-clavulanate, cefuroxime, or cefpodoxime as initial therapy 4

Reassessment Timeline

Reassess patients at 3-5 days if symptoms worsen or fail to improve 4, 3

At 7 days: If no improvement with initial management (antibiotic or watchful waiting), reassess to confirm ABRS diagnosis, exclude complications, and consider alternative diagnoses 4, 1

If Treatment Fails After 3-5 Days:

• Switch to different antibiotic class or broaden coverage 4, 3
• Consider high-dose amoxicillin-clavulanate if not already used 4
• Consider adding anaerobic coverage (clindamycin or metronidazole) for persistent cases 4

Adjunctive Therapies

Intranasal corticosteroids may be helpful as adjunct therapy, particularly for patients with nasal polyposis, marked mucosal edema, or treatment failure 4

Short-term oral corticosteroids are reasonable when patients fail initial treatment, have nasal polyps, or demonstrate marked mucosal edema 4

Imaging and Testing

Do NOT obtain imaging for uncomplicated acute rhinosinusitis 4, 6, 1

Plain radiographs have significant false-positive and false-negative results and are not recommended. 4

Consider CT imaging only for: 4, 3

• Suspected complications (orbital involvement, intracranial extension)
• Failure to improve after 21-28 days of treatment
• Recurrent acute rhinosinusitis requiring specialist evaluation

Red Flags Requiring Urgent Evaluation

Immediately evaluate for complications if patient develops: 4

• Facial swelling or erythema over involved sinus
• Visual changes or abnormal extraocular movements
• Proptosis or periorbital inflammation/edema/erythema
• Severe headache suggesting intracranial involvement
• Abnormal neurologic signs

These complications are rare but require urgent specialist referral and imaging. 4, 8

Patient Education

Instruct patients to contact you if: 4

• Symptoms worsen (especially severe headache or high fever)
• No improvement within 3-5 days of starting treatment
• New concerning symptoms develop

Emphasize prevention measures: 4

• Treat underlying allergic rhinitis appropriately
• Avoid cigarette smoke, pollution, and relevant allergens
• Manage viral URIs promptly

Evidence Quality Note

The benefit of antibiotics is marginal: only 5-11 more people per 100 are cured faster with antibiotics versus placebo, while 13 more per 100 experience adverse effects. 9 The number needed to treat is 19 for clinical diagnosis and 10 for radiographically confirmed cases, but the number needed to harm from side effects is only 8. 9 This supports the recommendation for watchful waiting as initial management for most patients with uncomplicated ABRS.